Rongtong Dictionary · Formula

Mahuang Decoction: Origins, Formula Logic, Historical Development, and Modern Pharmacology

Published and reviewed 2026-07-09

Mahuang Decoction is the potent diaphoretic of the Shanghan Lun's taiyang chapter, built from ephedra, cinnamon twig, apricot kernel, and honey-fried licorice into an exterior-opening structure for the taiyang cold-damage exterior-excess pattern. It is both a model for reading classical formula architecture and the mother of an entire ephedra-formula lineage, and because its sovereign herb's ephedrine and pseudoephedrine overlap with modern decongestant chemistry, it is a textbook case of a formula that requires professional pattern differentiation and pharmacist review rather than self-use.

Origin: a deliberately potent diaphoretic from the Shanghan Lun

Mahuang Decoction (Máhuáng Tāng) first appears in Zhang Zhongjing's Shanghan Lun (Treatise on Cold Damage, c. 200 CE), within the taiyang-disease chapter that anchors the six-channel diagnostic system. The text prescribes it for a patient with headache and fever, body and joint pain, aversion to cold, and — critically — the absence of sweating together with wheezing, and a tight, floating pulse. These signs (no sweat, wheeze, tight pulse) are the diagnostic anchors that separate it from Guizhi Decoction, which the same text reserves for the sweating, softer-pulsed taiyang wind-strike pattern. The pairing of the two formulas — one for an 'exterior-excess' and one for an 'exterior-deficiency' presentation — became a foundational reference point for the entire exterior-releasing method.

Importantly, the classical text does not treat this as a general cold remedy. It embeds the formula in a strict preparation-and-caution protocol: ephedra is decocted first and its foam skimmed off to reduce post-dose restlessness, only a light sweat is sought rather than a drenching one, and an explicit list of patients who must not be made to sweat is given. This 'benefit and toxicity share one source' caution is the enduring subject of discussion around the formula — not a simple label of 'induces sweating.'

Composition and the logic of the pairing

The formula has four ingredients: ephedra (Ephedrae Herba, sovereign), cinnamon twig (Cinnamomi Ramulus, minister), bitter apricot kernel (Armeniacae Semen Amarum, assistant), and honey-fried licorice (Glycyrrhizae Radix, envoy). The classical text specifies ephedra, cinnamon twig, apricot kernel, and licorice in a proportion frequently cited in the modern literature as roughly 9:6:6:3 by dried weight. This page identifies the entity and its internal logic only; it does not provide household dose conversions or decoction procedures.

In the traditional reading, ephedra opens the exterior, promotes sweating, and diffuses lung qi to calm wheezing; cinnamon twig works synergistically with ephedra to strengthen the diaphoretic action, and this sovereign–minister pair is the source of the formula's sweating power. Apricot kernel directs lung qi downward, forming an ascending–descending balance with ephedra that targets the wheeze specifically. Honey-fried licorice harmonizes and moderates the potent pair, protecting the center while tempering the vigor of ephedra and cinnamon. Together they express a single stated function: release the exterior by sweating, diffuse the lung, and calm wheezing.

Pattern, not disease: why it targets 'taiyang cold-damage exterior-excess'

In the textbook account, the mechanism is external wind-cold binding the surface: defensive yang is constrained, the interstices are shut, nutritive qi stagnates, producing aversion to cold, fever, absence of sweat, and body pain; because the lung governs the exterior, surface constraint impairs lung diffusion and the resulting counterflow becomes wheeze. The tight, floating pulse and thin white coating complete the picture.

Terms such as taiyang, defensive yang, and 'exterior-excess' are traditional functional constructs, not synonyms for modern anatomy or for a diagnosis such as viral upper respiratory infection. Pattern-based practice insists on matching formula to pattern: the same fever, if it presents with sweating and a softer pulse (exterior-deficiency), calls for Guizhi Decoction instead, while mild or mixed presentations have their own combined and lighter formulas. Similar symptoms do not imply the same pattern — which is precisely why the formula cannot be self-selected by name.

A thousand years of derivatives: from one formula to the 'ephedra-formula' family

Much of the formula's historical weight comes from its role as the mother of an entire lineage. Zhongjing himself modified it into several classics: adding gypsum yields Da Qinglong Decoction for surface cold with trapped interior heat; removing cinnamon twig and adding gypsum yields Maxing Shigan Decoction, which shifts the formula from acrid-warm to acrid-cool for lung heat with wheezing and sweating; combining with dried ginger, asarum, schisandra, and pinellia yields Xiao Qinglong Decoction for external cold with internal fluid; and dropping cinnamon twig yields the base wheeze-calming San'ao Decoction of the Song formulary. Later commentators repeatedly analyzed the boundaries between these formulas, making 'exterior-excess versus exterior-deficiency' and 'strength of diaphoresis' central questions of the cold-damage tradition.

Physician case records illustrate the same double edge — potent but disciplined. A widely retold Republican-era account describes a physician who, after losing children to mishandled cold-damage illness, decisively used Mahuang Decoction on a son presenting with the clear no-sweat, wheezing pattern, with rapid resolution; the story is usually cited to show that classical formulas can act quickly when the pattern is read correctly and carry sharply higher risk when it is not. Modern teaching lists the formula's key indicators as aversion to cold with fever, absence of sweat with wheeze, and a tight floating pulse, along with classical modification strategies — but these belong to professional practice and are not offered here as instructions.

Active constituents and a modern reading of the pairing

At the molecular level, the most-studied feature is the sovereign herb's ephedra alkaloids — chiefly l-ephedrine, d-pseudoephedrine, and methylephedrine. Review literature reports that ephedra contains well over a hundred compounds (alkaloids, flavonoids, tannins, volatile oils and others), with its diaphoretic, anti-asthmatic, and diuretic actions closely tied to the alkaloids — which are also the principal source of its toxicity. Ephedrine is a sympathomimetic amine that activates adrenergic receptors, strengthening and quickening the heartbeat, raising blood pressure, dilating the bronchi, and stimulating the central nervous system. This provides part of the material basis for the traditional 'sweating and wheeze-calming' experience while also explaining the intense modern scrutiny of its safety.

Formulation research adds a striking footnote. A Caco-2 monolayer study of the herb pairing (PMID 25660335) indicated that cinnamon twig, apricot kernel, and honey-fried licorice reduce intestinal absorption of ephedra alkaloids, leading the authors to hypothesize that the assistant and envoy herbs may temper ephedra's drastic diaphoresis and toxicity — a testable modern echo of the classical practices of 'moderating with licorice' and 'skimming the foam.' The caveat is essential: such work is in-vitro, animal, or network-pharmacology modelling — mechanistic exploration, not clinical proof — and cannot establish human outcomes for the compound formula.

What the evidence actually supports

The modern evidence must be separated into three tiers: the single compound ephedrine, the ephedra herb, and the Mahuang compound formula. For human randomized evidence, a systematic review and meta-analysis of 10 RCTs (PMID 34832979) assessed ephedrine-containing products for weight and lipids, finding roughly a 1.97 kg greater weight loss versus placebo — while explicitly noting accompanying increases in heart rate and blood pressure and describing ephedrine use as remaining controversial. The signal, where positive, comes bundled with cardiovascular risk; it is not a cost-free 'slimming' or 'sweating' remedy.

For the compound formula itself, most modern work is cellular and animal experimentation and network-pharmacology prediction in anti-inflammatory, anti-allergic, and anti-influenza directions (for example, exploration of Th17, TLR4/MyD88/TRAF6, and PI3K/Akt pathways); high-quality human RCTs are comparatively limited and clinical studies often mix modified formulas, different preparations, and co-medication. The defensible statement is that mechanistic and preliminary clinical research exists for specific scenarios with limited certainty — not that the formula is proven to treat influenza, asthma, or nephritis.

Quality standards, patent medicines, and the Western-drug overlap

For standardization, the Chinese Pharmacopoeia (2020) controls ephedra by morphological, microscopic, and chromatographic methods and requires that combined ephedrine hydrochloride and pseudoephedrine hydrochloride be not less than 0.80% — the alkaloid content is its statutory quality marker. Dozens of ephedra-containing classical formulas appear in the Pharmacopoeia, Mahuang, Xiao Qinglong, and Da Qinglong decoctions among them, and various ephedra-based patent medicines exist — but same-named or similarly named products differ markedly in composition, form, and dose and are not interchangeable.

As contextual overlap (relationship only, not an efficacy comparison): ephedra's key constituents, ephedrine and pseudoephedrine, are themselves defined chemical entities in modern pharmacy — pseudoephedrine is a common decongestant in many Western combination cold and rhinitis products, and ephedrine has historically served as a bronchodilator and pressor. Because of this ingredient overlap, ephedra-containing traditional formulas and such Western drugs can stack sympathomimetic effects if combined, raising cardiovascular risk; the same class of constituents is also tightly regulated in several jurisdictions as a stimulant, addictive substance, or drug precursor. This intersection of traditional and modern pharmacology is exactly why the formula requires professional management rather than self-use.

Safety boundaries and contraindications

Ephedra alkaloids affect heart rate, blood pressure, and the central nervous system and interact with many drugs — other sympathomimetics, monoamine oxidase inhibitors, certain antihypertensives, and pseudoephedrine-containing Western cold products among them. Hypertension, coronary and other cardiovascular disease, hyperthyroidism, glaucoma, prostatic hyperplasia, insomnia and anxiety states, and pregnancy, childhood, older age, hepatic or renal impairment, and polypharmacy all warrant professional review. Cinnamon twig, apricot kernel (containing amygdalin), and honey-fried licorice each carry their own cautions, including licorice's potential to affect blood pressure and electrolytes with prolonged or high-dose use.

The boundary of use matters most: the classical source itself demands only a light sweat, warns against exhausting yang through over-sweating, and lists numerous contraindications to diaphoresis. Persistent high fever, breathing difficulty, altered consciousness, severe chest pain, and marked dehydration are not self-treatment scenarios and require prompt medical care. Mahuang Decoction is an excellent model for understanding classical formula construction and the 'benefit-and-toxicity-share-one-source' principle — but its clinical use belongs to professional pattern differentiation and pharmacist review.

A checklist for reading any formula article

1. Composition and preparation: is a stated effect attributed to the canonical formula, a modified formula, a patent medicine, or the single ephedra compound? These must not be conflated.
2. Pattern versus disease: has a traditional pattern such as 'exterior-excess' been quietly swapped for a modern diagnosis like influenza or asthma?
3. Evidence tier: does the conclusion rest on in-vitro, animal, or network-pharmacology work, or on human randomized trials — and with what sample size, blinding, and risk of bias?
4. Safety and interactions: are ephedrine's cardiovascular risks, the overlap with pseudoephedrine-containing Western drugs, and the diaphoresis contraindications addressed?
5. Dose and procedure: responsible education identifies the entity and stops short of individual dosing, decoction methods, and modifications — prescriptions require a qualified physician and pharmacist.

Educational and academic reference only. It does not provide a diagnosis, prescription, dosage, or treatment recommendation. Ephedra-containing formulas have defined cardiovascular and central effects and are regulated in some regions; seek qualified care for persistent or urgent symptoms, and consult a licensed physician and pharmacist for any prescription.